BioHiTech Global (NASDAQ:BHTG) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.13) by 23.08 percent. This is a 23.08 percent decrease over losses of $(0.13) per share from the same period last year. The company reported quarterly sales of $742.88 thousand which missed the analyst consensus estimate of $1.51 million by 50.80 percent. This is a 47.94 percent decrease over sales of $1.43 million the same period last year.